Robert W.a. Sellers - 11 May 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: SVP, Corporate Controller
Issuer ticker: EW
Reported as of: 11 May 2024
Net transaction value: -$19,859
SEC form: 4
Accepted by SEC: 13 May 2024, 17:47:18 UTC
Prior SEC filing: 09 May 2024
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Robert W.a. Sellers filed Form 4 for Edwards Lifesciences Corp (EW) on 13 May 2024.

Key facts

This page summarizes Robert W.a. Sellers's Form 4 filing for Edwards Lifesciences Corp (EW).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 May 2024, 17:47.

Change

Previous filing in this sequence was filed on 09 May 2024.
Current net transaction value: -$19,859.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Tax liability

Transaction value: $19,859
Shares: -229
Change %: -1.3%
Price: $86.72
Shares after: 17,081
Date: 11 May 2024
Ownership: Direct

EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 20,409
Date: 11 May 2024
Ownership: By Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.